The NHS has set aside £1.3 billion to cope with compensation claims arising from the pandemic this year with claims for treatment delays, cancellations and misdiagnosis expected.
An annual report from NHS Resolution, which deals with patient disputes, shows that the health service anticipates it will need to pay out more than a billion pounds this financial year to settle claims arising from poor service during Covid.
At least three claims over serious side effects of Oxford-made vaccine AstraZeneca have been upheld in Norway, resulting in financial compensation. Dozens more are expecting a ruling in connection with coronavirus-jab reactions.
The Norwegian System of Patient Injury Compensation (NPE) will make payments to three applicants badly affected by the Oxford-AstraZeneca vaccine, it announced on Friday. It officially confirmed that the vaccine, currently suspended in the European country, has resulted in severe cases of blood clots and low platelet counts in these patients, one of whom died.
The Philippine Health Insurance Corporation (PhilHealth) recently announced its compensation package for those who will develop serious adverse effects (SAEs) following inoculation for COVID-19 that will lead to hospitalization, permanent disability or death. The said package and its guidelines are contained in its PhilHealth Circular No. 2021-0007 published on June 18, 2021.
New York-based Pfizer said the agreement will cost it between $165 million and $215 million, on a pretax basis, and will be offset by proceeds from the sale of most of its Shiley Inc. assets earlier this year as well as expected insurance reimbursements.
In July Health Secretary Matt Hancock claimed that conspiracy theorists are putting lives at risk
The UK government’s Vaccine Damage Payment scheme is proof that vaccines can be unsafe
Eligibility criteria Vaccine Damage Payment changed in 2015
Update October 2020: AstraZeneca protected from vaccine liability
Update November 2020: MHRA expects high volume of COVID-19 vaccine adverse drug reaction
Update December 2020: Pfizer is given protection from legal action by the UK government
Discussion around vaccinations can be very contentious. There’s great nuance in this area and a short post will not do justice to the complex issues surrounding the usefulness and safety of vaccines. Nevertheless, while vaccines may have their role in protecting target populations from disease, not all have been proven safe to an acceptable level as shown in the resources below.
The UK government’s Vaccine Damage Payment scheme is probably the strongest proof that vaccines can be unsafe. Under the Vaccine Damage Payment scheme, people who have been severely disabled as a result of a vaccination against certain diseases can be eligible for a one-off tax-free payment of £120,000.
Conspiracy theorists are putting lives at risk?
It is an objective fact that a compensation scheme exists for those who have been damaged by vaccines. Nevertheless, Health Secretary Matt Hancock claimed that conspiracy theorists are putting lives at risk:
“Those who promulgate lies about dangers of vaccines that are safe and have been approved–they are threatening lives…”
Clearly, concerns about the safely of vaccines cannot be lies if there is a vaccine damage compensation scheme in place.
Eligibility changed in 2015
Eligibility requirements for vaccines covering certain diseases are listed and change over time. Interestingly, sometime around 2015, damage from vaccines for influenza caused by pandemics are explicitly listed as not eligible.
We do not know how the government compiles is eligibility criteria or why this change was made. However, it would be worthwhile to keep an eye on this list to see if the status of the upcoming COVID-19 vaccines.
AstraZeneca protected from vaccine liability
Update 1 August 2020: On 30 July 2020, Reuters reported that AstraZeneca, the UK government’s partner for developing its COVID-19 vaccine, will be exempt from coronavirus vaccine liability claims in most countries. The countries have not been named but Ruud Dobber, a member of Astra’s senior executive team, commented:
“This is a unique situation where we as a company simply cannot take the risk if in … four years the vaccine is showing side effects.
In the contracts we have in place, we are asking for indemnification. For most countries it is acceptable to take that risk on their shoulders because it is in their national interest.”
MHRA expects high volume of COVID-19 vaccine adverse drug reaction
Update November 2020: It came to light in mid-November that the UK’s Medicines & Healthcare products Regulatory Agency (MHRA) put out a contract award notice for an Artificial Intelligence (AI) software tool. It appears they expect a high volume of COVID-19 vaccine Adverse Drug Reaction (ADRs) from the upcoming vaccines:
…it is not possible to retrofit the MHRA’s legacy systems to handle the volume of ADRs that will be generated by a Covid-19 vaccine. Therefore, if the MHRA does not implement the AI tool, it will be unable to process these ADRs effectively.
Pfizer given legal indemnity
Update 2 December 2020:According to the Independent, Pfizer now has a legal indemnity from being sued by patients who develop any complications from its new mRNA vaccine that will be rolled out in the UK. NHS staff providing the vaccine will also be protected.
Traffic log cookies are used to measure site traffic. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.